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Medicinal herbs are significant source of pharmaceutical drugs. Latest trends have shown increasing demand of
phytodrugs and some medicinal herbs have proven hepatotprotective potential. Silymarin, a flavonol lignan mixture)
extracted from the Silybum marianum (milk thistle) is a popular remedy for hepatic diseases. Today every herbal
company is marketing formulations for liver disorders but the actual scene is that only selected medicinal herbs have
been tested for hepatotprotective activity. Some herbal formulations claiming to be hepatoprotective may actually
contain chemical constituents having hepatotoxic potential. Andrographolide (Andrographis paniculata), Glycyrrhizin
(Glychyrrhiza glabra), Picrrorihzin (Picrorrhiza kurroa) and Hypo-phyllanthin (Phyllanthus niruri) are potential
candidates with hepatoprotective activity. The article reviews latest trends in testing of isolated constituents with
hepatoprotective activity.
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Alternative systems of medicine viz. Ayurveda, Siddha, and Traditional Chinese Medicine have become more
popular in recent years.1 Medicinal herbs and extracts prepared from them are widely used in the treatment of liver
diseases like hepatitis, cirrhosis, and loss of appetite.2 Medicinal herb is a biosynthetic laboratory, for chemical
compounds like glycosides, alkaloids, resins, oleoresins, etc. These exert physiological and therapeutic effect.3  The
compounds that are responsible for medicinal property of the drug are usually secondary metabolites.
 
A number of recent reviews have focused on the adverse effects of herbal products.4 In the current review, we
will highlight on herbs known to be hepatoprotective, mechanisms of hepatoprotectivity, and clinical documentation.5
In fact some herbal products claiming to be hepatoprotective may actually be having some components with
hepatotoxic potential.
Silybum marianum, Picrrorhiza kurroa, Andrographis paniculata, Phyllanthus niruri, and Eclipta alba are
proven hepatoprotective medicinal herbs, which have shown genuine utility in liver disorders. 6 These plants are used
widely in hepatotprotective preparations and extensive studies have been done on them. Their discussion is beyond the
scope of the article.
 
Taraxacum officinale
Traditionally Taraxacum officinale has been used as a remedy for jaundice and other disorders of the liver and
gallbladder, and as a remedy for counteracting water retention. Generally, the roots of the plant have the most activity
regarding the liver and gallbladder. Oral administration of extracts from the roots of Taraxacum officinale has been
shown to act as a cholagogue, increasing the flow of bile.7 Bitter constituents like taraxecerin and taraxcin are active
constituents of the medicinal herb.8
 
Cichorium intybus
Cichorium intybus is a popular Ayurvedic remedy for the treatment of liver diseases. It is commonly known as
kasni and is part of polyherbal formulations used in the treatment of liver diseases. In mice, liver protection was
observed at various doses of Cichorium intybus but optimum protection was seen with a dose of 75 mg/kg given 30
minutes after CCl4 intoxication.9 In preclinical studies an alcoholic extract of the Cichorium intybus was found to be
effective against chlorpromazine-induced hepatic damage in adult albino rats. A bitter glucoside, Cichorin
(C32H34O19) has been reported to be the active constituent of the herb.
Solanum nigrum
In Ayurveda, the drug is known as kakamachi. Aromatic water extracted from the drug is widely prescribed by
herbal vendors for liver disorders. Although clinical documentation is scare as far as hepatoprotective activity is
concerned, but some traditional practitioners have reported favorable results with powdered extract of the plant.
Glychyrrhiza glabra
Glychyrrhiza glabra, commonly known as licorice contains triterpene saponin, known as glycyrrhizin, which
has potential hepatotprotective activity. It belongs to a group of compounds known as sulfated polysaccharides. Several
studies carried out by Japanese researchers have shown glycyrrhizin to be for anti-viral and it has potential for
therapeutic use in liver disease. 10
Experimental hepatitis and cirrhosis studies on rats found that it can promote the regeneration of liver cells and
at the same time inhibit fibrosis. Glycyrrhizin can alleviate histological disorder due to inflammation and restore the
liver structure and function from the damage due to carbon tetrachloride. The effects including: lowering the SGPT,
reducing the degeneration and necrosis and recovering the glycogen and RNA of liver cells. Effects of glycyrrhizin has
been studied on free radical generation and lipid peroxidation in primary cultured rat hepatocytes.11
Favorable results have been reported in children suffering from cytomegalovirus after treating with
glycyrrhizin.12
Wilkstroemia indica
W. indica is a Chinese herb and has been evaluated in patients suffering from hepatitis B. A dicoumarin,
daphnoretin is the active constituent of the herb. The drug has shown to suppress HbsAG in Hep3B cells. It is said to
activator of protein kinase C.13
 
Curcuma longa
Like silymarin, turmeric has been found to protect animal livers from a variety of hepatotoxic substances,
including carbon tetrachloride,15 galactosamine, pentobarbitol, 1-chloro-2,4-dinitrobenzene,7 4-hydroxy-nonenal,16
and paracetamol. Diarylhepatonoids including Curcumin is the active constituent of the plant.
 
Tephrosia purpurea
In Ayurveda, the plant is known as sharpunkha. Alkali preparation of the drug is commonly used in treatment
of liver and spleen diseases. In animal models, it offered protective action against carbon tetrachloride and
D-galalactosamine poisoning. 17 The roots, leaves and seeds contain tephrosin, deguelin and quercetin. The
hepatotprotective constituent of the drug is still to be proved.
 
References
 1.      Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the
United States – Prevalence, costs and patterns of use. NEJM 1993,328-246-252.
2.      Cupp MJ. Herbal remedies: adverse effects and drug interactions. Am Fam Physician 1999: 59: 1239 – 44.
3.      PDR for herbal medicines. First edition. Montvale, New Jersey .1998: 1177-1178.
4.      De Smet PAGM, Keller K, Hansel R, Chandler RF, eds Adverse effects of herbal drugs. Berlin, Germany:
Springer – Verlag, 1997.
5.      Samir Malhotra, Amritpal Singh, G.Munjal. Hepatotoxic potential of commonly used herbal products.
Gastroenterology Today 2001: 5: 110-111.Vol.V No.2.ISSN 0971-8222.
6.      Bisset NG, ed. Herbal drugs and phytopharmaceuticals. A handbook for practice on a specific basis. Stuttgart:
Medpharm Scientific, 1994: 326-8.
7.      Vogel G. Natural substances with effects on the liver. In: Wagner H, Wolff P, eds. New Natural Products and
Plant Drugs with Pharmacological, Biological or Therapeutic Activity. Heidelberg: Springer-Verlag; 1977.
8.      Cordatos E. Taraxacum officinale. In: Murray M, Pizzorno J, eds. A Textbook of Natural Medicine. Seattle:
Bastyr University Press; 1992.
9.      H. Kalantari PhD, M. Rastmanesh Pharm D. Protective Property of Cichorium Intybus in CCL4 Induced Liver
Damage in mice. School of Pharmacy, Ahwaz University of Medical Sciences, Ahwaz, Iran.
10.  Sanwa Kagaku Kenkyusha Co. Ltd.: Marmen Pharmaceutical Co. Ltd. - Japanese patent. Chem Abst. 102:
32261 b (1985).
11.  Zhao, M. Q. et al.: Acta Pharm. Sin. IS: 325 (1983).
12.  Numazaki, K., et al. Effect of glycyrrhizin in children with liver dysfunction associated with cytomegalovirus
infection. Tohoku J Exp Med. 1994 Feb; 172(2): 147-53.
13.  Chen HC, Chou CK, Kuo YH, Yeh SF. Identification of a protein kinase C (PKC) activator, dephnoretin, that
suppresses hepatitis B virus gene expression in human hepatoma cells. Biochem Pharmacol 1996; 52:1025-
1032.
14.  Duke JA (1985) Die amphocholeretische Wirkung der Fumaria officinalis .Z Allg Med 34:1819.
15.  Srinivas L, Shalini VK. DNA damage by smoke: Protection by turmeric and other inhibitors of ROS. Free
Radical Biol Med 1991; 11:277-283.
16.  Selvam R, Subramanian L, Gayathri R, et al. The anti-oxidant activity of turmeric (Curcuma longa). J
Ethnopharmacol 1995; 47:59-67.
17.   M.Sree Rama Murthy, M.Srinivasan, R&D Department, TTK Pharma Limited. Hepatotprotective Effect of
Tephrosia pupurea in experimental animals. Indian Journal of Pharmacology 1993; 25:34-36.
18.  Adzet T, Camarasa J, Laguna JC. Hepatoprotective activity of polyphenolic compounds from Cynara scolymus
against CCl4 toxicity in isolated rat hepatocytes. Departamento de Farmacognosia y Farmacodinamia, Facultad
de Farmacia, Nucleo Universitario de Pedralbes, Barcelona, Spain. J Nat Prod 1987 Jul-Aug; 50(4): 612-7.
19.  Datta S, Sinha S, Bhattacharyya P. Hepatoprotective activity of a herbal protein CI-1, purified from Cajanus
indicus against beta-galactosamine HCl toxicity in isolated rat hepatocytes. Department of Chemistry, Bose
Institute, 93/1, A.P.C. Road, Calcutta 700009, India. Phytother Res 1999 Sep; 13(6): 508-12.
 
 
